Screening for Chlamydial Infection: U.S. Preventive Services Task Force Recommendation Statement

  1. U.S. Preventive Services Task Force*
  1. From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
    1. Figure.
      View larger version:
      Figure. Screening for chlamydial infection.

      For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents, please go to http://www.preventiveservices.ahrq.gov. *Chlamydial infection results in few sequelae in men. Therefore, the major benefit of screening men would be to reduce the likelihood that infected and untreated men would pass the infection to sexual partners. There is no evidence that screening men reduces the long-term consequences of chlamydial infection in women. Because of this lack of evidence, the USPSTF could not assess the balance of benefits and harms and concluded that the evidence is insufficient to recommend for or against routinely screening men. †Information from reference 1.

    « Previous | Next Article »Table of Contents